everolimus

The medicine is used in adults to prevent the immune system from rejecting a transplanted kidney, heart, or liver. It is used in combination with other medicines, such as cyclosporine, tacrolimus, or corticosteroids.

Form: tablets

ATC: L04AA18

Manufacturer: Novartis Pharma GmbH, Salutas Pharma GmbH

The medicine is used in adults to prevent the immune system from rejecting a transplanted kidney, heart, or liver.

Form: tablets

ATC: L04AA18

Manufacturer: Novartis Pharma GmbH, Salutas Pharma GmbH

The medicine is used in adults to prevent the immune system from rejecting a transplanted kidney, heart, or liver.

Form: tablets

ATC: L04AA18

Manufacturer: Novartis Pharma GmbH, Salutas Pharma GmbH

The medicine is used in adults to prevent the immune system from rejecting a transplanted kidney, heart, or liver. It is taken together with other medicines, such as cyclosporine, tacrolimus, or corticosteroids.

Form: tablets

ATC: L04AA18

Manufacturer: Novartis Pharma GmbH, Salutas Pharma GmbH

The medicine is used in adult patients to prevent the body's immune system from rejecting a transplanted kidney, heart, or liver.

Form: tablets

ATC: L04AA18

Manufacturer: Novartis Farma S.p.A., Novartis Farma S.p.A., Novartis Farmacéutica, S.A., Novartis Farma-Productos Farmacéuticos S.A., Novartis (Hellas) S.A.C.I., Novartis Hungary Ltd., Novartis Pharma B.V., Novartis Pharma GmbH, Novartis Pharma GmbH, Novartis Pharma S.A.S, Novartis Pharmaceuticals S.R.L., Novartis Sverige AB

The medicine is used in adult patients to prevent the body's immune system from rejecting a transplanted kidney, heart, or liver.

Form: tablets

ATC: L04AA18

Manufacturer: Novartis Farma S.p.A., Novartis Farma S.p.A., Novartis Farmacéutica, S.A., Novartis Farma-Productos Farmacéuticos S.A., Novartis (Hellas) S.A.C.I., Novartis Hungary Ltd., Novartis Pharma B.V., Novartis Pharma GmbH, Novartis Pharma GmbH, Novartis Pharma S.A.S, Novartis Pharmaceuticals S.R.L., Novartis Sverige AB

The medicine is used in adult patients to prevent the body's immune system from rejecting a transplanted kidney, heart, or liver.

Form: tablets

ATC: L04AA18

Manufacturer: Novartis Farma S.p.A. Novartis Farma S.p.A. Novartis Farmaceutica S.A. Novartis Farma-Productos Farmaceuticos S.A. Novartis (Hellas) S.A.C.I. Novartis Hungary Ltd. Novartis Pharma B.V. Novartis Pharma GmbH Novartis Pharma GmbH Novartis Pharma S.A.S Novartis Pharmaceuticals S.R.L. Novartis Sverige AB

It is an anticancer medicine used in adult patients with advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.

Form: tablets

ATC: L01EG02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

It is an anticancer medicine used in adult patients with advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.

Form: tablets

ATC: L01EG02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This is an anticancer medicine used in adult patients with advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.

Form: tablets

ATC: L01EG02

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicinal product is used in adult patients for the treatment of advanced breast cancer (in postmenopausal women, in combination with exemestane), advanced neuroendocrine tumours (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.

Form: tablets

ATC: L01XE10

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used in adult patients with advanced breast cancer (in postmenopausal women, in combination with exemestane), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.

Form: tablets

ATC: L01XE10

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used in adult patients for the treatment of advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.

Form: tablets

ATC: L01XE10

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is used in adult patients for the treatment of advanced breast cancer (in postmenopausal women), advanced neuroendocrine pancreatic tumors, and advanced renal cell carcinoma.

Form: tablets

ATC: L01EG02

Manufacturer: Genepharm S.A., Pharmacare Premium Ltd., Pharmadox Healthcare Ltd., STADA Arzneimittel AG, STADA Arzneimittel GmbH

This is an anticancer medicine used in adult patients for the treatment of advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors of the pancreas, and advanced renal cell carcinoma.

Form: tablets

ATC: L01EG02

Manufacturer: Genepharm S.A., Pharmacare Premium Ltd., Pharmadox Healthcare Ltd., STADA Arzneimittel AG, STADA Arzneimittel GmbH

This is an anticancer medicine used in adult patients for the treatment of advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.

Form: tablets

ATC: L01XE10

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This is an anticancer medicine used in adult patients with advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.

Form: tablets

ATC: L01XE10

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This is an anticancer medicine used in adults for the treatment of advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced kidney cancer.

Form: tablets

ATC: L01XE10

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This is an anticancer medicine used in adults for the treatment of advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.

Form: tablets

ATC: L01EG02

Manufacturer: Genepharm S.A., Pharmacare Premium Ltd., Pharmadox Healthcare Ltd.

The medicinal product is used in adult patients for the treatment of advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.

Form: tablets

ATC: L01EG02

Manufacturer: Genepharm S.A., Pharmacare Premium Ltd., Pharmadox Healthcare Ltd.

The medicine is used in adult patients for the treatment of advanced breast cancer (in postmenopausal women), advanced neuroendocrine tumors (originating from the stomach, intestines, lungs, or pancreas), and advanced renal cell carcinoma.

Form: tablets

ATC: L01EG02

Manufacturer: Genepharm S.A., Pharmacare Premium Ltd., Pharmadox Healthcare Ltd.